91 related articles for article (PubMed ID: 21790793)
1. Randomized, double-blind, split-side comparison study of moisturizer containing licochalcone vs. 1% hydrocortisone in the treatment of infantile seborrhoeic dermatitis.
Wananukul S; Chatproedprai S; Charutragulchai W
J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):894-7. PubMed ID: 21790793
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, split-side, comparison study of moisturizer containing licochalcone A and 1% hydrocortisone in the treatment of childhood atopic dermatitis.
Wananukul S; Chatproedprai S; Chunharas A; Limpongsanuruk W; Singalavanija S; Nitiyarom R; Wisuthsarewong W
J Med Assoc Thai; 2013 Sep; 96(9):1135-42. PubMed ID: 24163988
[TBL] [Abstract][Full Text] [Related]
3. Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study.
Udompataikul M; Srisatwaja W
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):660-5. PubMed ID: 20840345
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis.
Wannanukul S; Chiabunkana J
J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S68-71. PubMed ID: 16083165
[TBL] [Abstract][Full Text] [Related]
5. Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults.
Papp KA; Papp A; Dahmer B; Clark CS
J Am Acad Dermatol; 2012 Jul; 67(1):e11-5. PubMed ID: 22101215
[TBL] [Abstract][Full Text] [Related]
6. Randomized investigator-blinded comparative study of moisturizer containing 4-t-butylcyclohexanol and licochalcone A versus 0.02% triamcinolone acetonide cream in facial dermatitis.
Boonchai W; Varothai S; Winayanuwattikun W; Phaitoonvatanakij S; Chaweekulrat P; Kasemsarn P
J Cosmet Dermatol; 2018 Dec; 17(6):1130-1135. PubMed ID: 29411520
[TBL] [Abstract][Full Text] [Related]
7. Is metronidazole 0.75% gel effective in the treatment of seborrhoeic dermatitis? A double-blind, placebo controlled study.
Ozcan H; Seyhan M; Yologlu S
Eur J Dermatol; 2007; 17(4):313-6. PubMed ID: 17540638
[TBL] [Abstract][Full Text] [Related]
8. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
[TBL] [Abstract][Full Text] [Related]
9. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
[TBL] [Abstract][Full Text] [Related]
10. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
Seckin D; Gurbuz O; Akin O
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
[TBL] [Abstract][Full Text] [Related]
11. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.
Cicek D; Kandi B; Bakar S; Turgut D
J Dermatolog Treat; 2009; 20(6):344-9. PubMed ID: 19954391
[TBL] [Abstract][Full Text] [Related]
12. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
13. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
Schwartz RH
Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
[TBL] [Abstract][Full Text] [Related]
14. A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis.
Bissonnette R; Maari C; Provost N; Bolduc C; Nigen S; Rougier A; Seite S
J Cosmet Dermatol; 2010 Mar; 9(1):16-21. PubMed ID: 20367668
[TBL] [Abstract][Full Text] [Related]
15. Locoid vs betnovate lotion in the treatment of seborrhoeic and atopic dermatitis of the scalp.
Turnbull BC
N Z Med J; 1982 Oct; 95(718):738-40. PubMed ID: 6216427
[TBL] [Abstract][Full Text] [Related]
16. Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison.
Unholzer A; Varigos G; Nicholls D; Schinzel S; Nietsch KH; Ulbricht H; Korting HC
Infection; 2002 Dec; 30(6):373-6. PubMed ID: 12478328
[TBL] [Abstract][Full Text] [Related]
17. A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream.
Katsambas A; Antoniou C; Frangouli E; Avgerinou G; Michailidis D; Stratigos J
Br J Dermatol; 1989 Sep; 121(3):353-7. PubMed ID: 2529893
[TBL] [Abstract][Full Text] [Related]
18. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
[TBL] [Abstract][Full Text] [Related]
19. Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo.
Dreno B; Moyse D
Eur J Dermatol; 2002; 12(6):549-52. PubMed ID: 12459525
[TBL] [Abstract][Full Text] [Related]
20. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
Elewski B
Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
